Does APREPITANT Cause Therapeutic product effect incomplete? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Therapeutic product effect incomplete have been filed in association with APREPITANT (CINVANTI). This represents 1.3% of all adverse event reports for APREPITANT.
74
Reports of Therapeutic product effect incomplete with APREPITANT
1.3%
of all APREPITANT reports
70
Deaths
72
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From APREPITANT?
Of the 74 reports, 70 (94.6%) resulted in death, 72 (97.3%) required hospitalization, and 71 (95.9%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which APREPITANT Alternatives Have Lower Therapeutic product effect incomplete Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL